Citadel Advisors
EVAR

Citadel Advisors’s Lombard Medical, Inc. EVAR Stock Holding History

Citadel Advisors’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-44,751
Closed -$25K – 8443
2017
Q2 		$25K Buy
+44,751
New +$23.3K ﹤0.01% 7246
2016
Q3 		– Sell
-32,359
Closed -$35K – 8130
2016
Q2 		$35K Sell
32,359
-103,238
-76% -$144K ﹤0.01% 6487
2016
Q1 		$142K Sell
135,597
-38,764
-22% -$34.5K ﹤0.01% 5865
2015
Q4 		$236K Buy
174,361
+13,756
+9% +$32.5K ﹤0.01% 5575
2015
Q3 		$585K Buy
160,605
+1,605
+1% +$6.15K ﹤0.01% 4581
2015
Q2 		$701K Hold
159,000
– – ﹤0.01% 4473
2015
Q1 		$641K Sell
159,000
-949
-0.6% -$4.88K ﹤0.01% 4545
2014
Q4 		$1.04M Buy
159,949
+1,774
+1% +$11.6K ﹤0.01% 3721
2014
Q3 		$1.22M Buy
158,175
+2,175
+1% +$14.4K ﹤0.01% 3468
2014
Q2 		$1.12M Buy
+156,000
New +$1.27M ﹤0.01% 3354

Other funds holding EVAR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's EVAR Position: Q3 2017 in Review

Citadel Advisors sold out of Lombard Medical, Inc. (EVAR) in Q3 2017, closing a stake of 44,751 shares — an estimated $25K sold.

Citadel Advisors first reported a position in EVAR in Q2 2014 and held it in 10 quarters. The position peaked at $1.22M in Q3 2014. 11 funds tracked by Wall St. Rank hold EVAR as of Q3 2017.

  • Citadel Advisors reported no remaining Lombard Medical, Inc. position as of Q3 2017 after selling out during the quarter.
  • Citadel Advisors sold 44,751 Lombard Medical, Inc. shares in Q3 2017, an estimated $25K.
  • Citadel Advisors first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 10 quarters.
  • Citadel Advisors's Lombard Medical, Inc. position peaked at $1.22M in Q3 2014.
  • 11 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q3 2017.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.